Verrica Pharmaceuticals Inc. (VRCA)
NASDAQ · Healthcare
Verrica Pharmaceuticals Inc. Total Liabilities 2021–2025
Verrica Pharmaceuticals Inc. annual/quarterly total liabilities history from 2021 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Verrica Pharmaceuticals Inc. total liabilities for the quarter ending December 31, 2025 were 22.4M, a 65.02% decrease year-over-year.
- Verrica Pharmaceuticals Inc. total liabilities for 2025 were 22.4M, a 65.02% decrease from 2024.
- Verrica Pharmaceuticals Inc. total liabilities for 2024 were 64.0M, a 3.49% increase from 2023.
- Verrica Pharmaceuticals Inc. total liabilities for 2023 were 61.8M, a 1218.98% increase from 2022.
- Verrica Pharmaceuticals Inc. total liabilities for 2022 were 4.7M.
Total Liabilities
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Verrica Pharmaceuticals Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $22 |
| 2024 | $64 |
| 2023 | $62 |
| 2022 | $5 |
| 2021 | $48 |
| Verrica Pharmaceuticals Inc. Quarterly Total Liabilities (Millions of US $) | |
|---|---|
| 2025-12-31 | $22 |
| 2024-12-31 | $64 |
| 2023-12-31 | $62 |
| 2022-12-31 | $5 |
| 2021-12-31 | $48 |
Verrica Pharmaceuticals Inc. Total Liabilities — FAQ
Verrica Pharmaceuticals Inc. (VRCA) total liabilities over the last 5 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see VRCA's total liabilities history?
The chart and table above show Verrica Pharmaceuticals Inc.'s total liabilities by year and by quarter, including the growth rate.